1-3 of 3
Giuseppe Tonini, MD
Close
Sort by
Journal Articles

Denosumab For The Treatment Of Hypercalcemia Of Malignancy Refractory To IV Bisphosphonates In Patients With Hematologic Malignancies

Rasim Gucalp, MD, Karl Insogna, MD, Mimi Hu, MD, Ilya Glezerman, MD, Sophie Leboulleux, MD, Waldemar Misiorowski, MD, Bennett Yu, MD, Paul Zorsky, MD, Diego Tosi, MD, Alberto Bessudo, MD, Arnaud Jaccard, MD, Giuseppe Tonini, MD, Wendy Ying, PhD, Ada H. Braun, MD, PhD, Rajul K. Jain, MD
Journal: Blood
Blood (2013) 122 (21): 2536.
https://doi.org/10.1182/blood.V122.21.2536.2536
Published: 2013
Journal Articles

Physiologic Inhibitors of Coagulation, Thrombophilic Acquired Factors and Venous Thromboembolism in Gastrointestinal Cancer Patients.

Gaia Schiavon, MD, Odoardo M. Olimpieri, MD, Barbara Giannetti, BSc, Maria C. Tirindelli, MD, Annalisa La Cesa, MD, Domenico Borzomati, MD, Bruno Vincenzi, MD, Roberto Coppola, MD, Giuseppe Tonini, MD, Giuseppe Avvisati, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 4044.
https://doi.org/10.1182/blood.V104.11.4044.4044
Published: 2004
Journal Articles

Thrombophilic Genetic Mutations Have No Impact in the Pathogenesis of Thromboembolism in Gastro-Intestinal Cancer Patients.

Odoardo M. Olimpieri, MD, Gaia Schiavon, MD, Barbara Giannetti, BSc, Maria C. Tirindelli, MD, Daniele Santini, MD, Sergio Valeri, MD, Bruno Vincenzi, MD, Roberto Coppola, MD, Giuseppe Tonini, MD, Giuseppe Avvisati, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 3518.
https://doi.org/10.1182/blood.V104.11.3518.3518
Published: 2004